Zepp Health Corporation
ZEPP
$8.62
-$0.38-4.22%
NYSE
| 12/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 43.03% | -28.27% | -48.91% | -56.04% | -57.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 43.03% | -28.27% | -48.91% | -56.04% | -57.57% |
| Cost of Revenue | 34.93% | -30.57% | -54.10% | -66.33% | -68.10% |
| Gross Profit | 56.94% | -23.95% | -38.78% | -19.50% | -2.08% |
| SG&A Expenses | 37.86% | 15.93% | 15.20% | -14.12% | -13.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.02% | -16.87% | -32.71% | -50.89% | -52.00% |
| Operating Income | 56.69% | -1,527.80% | -1,009.14% | 5.03% | 28.17% |
| Income Before Tax | 61.83% | -1,643.81% | -4,093.67% | 7.87% | 37.95% |
| Income Tax Expenses | -84.76% | 389.15% | -- | 102.84% | 101.98% |
| Earnings from Continuing Operations | 70.27% | -2,819.38% | -5,084.59% | -7.76% | 26.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 266.67% | -70.37% | -61.54% | 13.38% |
| Net Income | 70.25% | -2,783.19% | -4,622.53% | -7.94% | 26.45% |
| EBIT | 56.69% | -1,527.80% | -1,009.14% | 5.03% | 28.17% |
| EBITDA | 64.38% | -401.50% | -412.82% | 5.07% | 29.97% |
| EPS Basic | 69.88% | -2,608.26% | -4,351.30% | -0.96% | 30.52% |
| Normalized Basic EPS | 50.49% | -615.90% | -2,892.47% | -- | 34.33% |
| EPS Diluted | 68.12% | -1,362.95% | -5,228.13% | -0.96% | 30.23% |
| Normalized Diluted EPS | 50.49% | -615.90% | -3,051.14% | -- | 34.33% |
| Average Basic Shares Outstanding | -1.24% | 6.51% | 6.27% | 6.92% | 5.87% |
| Average Diluted Shares Outstanding | -1.23% | 6.51% | 0.88% | 6.92% | 5.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |